Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes

Overview of attention for article published in Vascular Health and Risk Management, April 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 131 Dimensions

Readers on

mendeley: 175 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 131 publications that cite this research output.

131

The most recent citing publications are shown below. View all 131 publications that cite this research output on Dimensions.

Real-world effectiveness of iGlarLixi in individuals with T2D sub-optimally controlled on oral anti-diabetic drugs with or without basal insulin in daily practice in Saudi Arabia (EMPOWER study)

Article in Endocrine and Metabolic Science (June 2024)

Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement

Article in The Journal of Clinical Endocrinology & Metabolism (February 2024)

Real-world Clinical Effectiveness on Glycaemic Parameters, Safety and Additional Benefits of Glargine U300 (Toujeo®) Initiation after Oral Antidiabetic Drug Failure in Insulin-naïve Patients with type 2 Diabetes Mellitus

Article in Indian Journal of Endocrinology and Metabolism (October 2023)